Skip to main content

Table 3 MMGBSA analysis indicating binding energy of all the complexes

From: Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target

Complex (Replica-1)

vdW

EEL

ESURF

EGB

ΔG TOTAL

H-209-KRASG12C

-55.26

-9.38

-4.51

28.34

-45.82

ZINC001458505494-KRASG12C

-61.41

-11.74

-6.01

26.56

-47.61

SANC00905-KRASG12C

-71.52

-20.78

-9.10

18.70

-53.71

PubChem-CID11968893-KRASG12C

-69.60

-17.03

-8.53

23.89

-50.28

Sotorasib-KRASG12C

-52.47

-7.00

-4.06

29.21

-45.42

Complex (Replica-2)

vdW

EEL

ESURF

EGB

ΔG TOTAL

H-209-KRASG12C

-48.78

-9.82

-5.86

25.38

-39.08

ZINC001458505494-KRASG12C

-42.78

-5.46

-4.81

17.82

-35.24

SANC00905-KRASG12C

-66.44

-4.81

-6.86

20.80

-57.33

PubChem-CID11968893-KRASG12C

-66.58

-10.66

-6.66

32.41

-51.50

Sotorasib-KRASG12C

-51.98

-11.82

-6.09

29.10

-40.80

  1. vdW = van der Waals energy, EEL = electrostatic energy, ESURF = surface areas energy, EGB = the electrostatic contribution to the solvation free energy